INSULIN RESISTANCE IN SKELETAL-MUSCLES OF PATIENTS WITH DIABETES-MELLITUS
INSULIN RESISTANCE IN SKELETAL-MUSCLES OF PATIENTS WITH DIABETES-MELLITUS
复制标题
DOI:
10.1002/dmr.5610050602
复制
发表时间:
1989-09-01
期刊:
影响因子:
--
通讯作者:
BECKNIELSEN, H
中科院分区:
文献类型:
--
作者:
BECKNIELSEN, H
Until 1970 insulin resistance was not considered to play a major clinical role. Since then characterization of the insulin receptor has opened up a new field for investigation of insulin action. Thus, it is now known that some degree of insulin resistance is a common feature of almost all diabetic syndromes and of many physiological and pathophysiological states with abnormal or even normal glucose tolerance. Hyperinsulinemia can compensate for insulin resistance, resulting in a normal or only slightly impaired glucose tolerance-compensated insulin resistance-as seen in obesity. If the p-cells are unable to produce the amount of insulin necessary to compensate for insulin resistance, hyperglycemia develops: uncompensated insulin resistance. This type of insulin resistance plays an important role in the pathogenesis of diabetes mellitus but may also affect the treatment of this disease. Furthermore, insulin resistance may be involved in the development of late diabetic complications. Insulin resistance and hyperinsulinemia, for example, may add to the development of arteriosclerosis in diabetes (macroangiopathy)'and, through an increase in blood glucose levels, may also stimulate glucose uptake in non-insulin-sensitive tissues, which may add to, for example, sorbitol production (microangiopathy). 2 Insulin is also a growth factor, and hyperinsulinemia has therefore been claimed to take part in development of late diabetic complications through stimulation of cell growth. 2 Thus, insulin resistance seems to be involved in both the pathogenesis of diabetes and the development of microangiopathy and macroangiopathy and seems to play a major role in glucose homeostasis during treatment of diabetes.